Clinical Trial

Reducing Pneumonia with LMA in Lung Wedge Resection

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 13, 2025 (before its estimated March 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This retrospective cohort study aims to evaluate whether spontaneous breathing laryngeal mask anesthesia (LMA-SBA) reduces the incidence of postoperative pneumonia compared to single-lung isolation mechanical ventilation in patients undergoing thoracoscopic wedge resection. Using propensity score overlap weighting, we will adjust for multiple confounders, including age, COPD, surgical duration, and preoperative laboratory values. Secondary outcomes include postoperative recovery time, fever severity, white blood cell count, neutrophil percentage, length of hospital stay, and ICU admission rate. The study has been approved by the Ethics Committee of the First Affiliated Hospital of Shandong First Medical University (Approval No. YXLL-KY-2025(037)).
Trial Details
NCT Number NCT06873958
Lead Sponsor Hai Feng
Conditions Pneumonia, Postoperative, Anesthesia, Thoracic Surgery, Thoracoscopic Wedge Resection
Enrollment 700 participants
Start Date 2025-03-15
Primary Completion 2025-03-30 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-13